Vanda Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 5, 2026

Rhea-AI Summary

Vanda Pharmaceuticals (Nasdaq: VNDA) will release its second quarter 2026 financial results on Wednesday, August 5, 2026, after the market close. Management will host a conference call and webcast at 4:30 PM ET the same day to review results and discuss corporate activities.

Investors can join by phone using domestic number 1-888-596-4144 or international number 1-646-968-2525 with passcode 1843107, or via webcast on Vanda's website. A replay will be available from 8:30 PM ET on August 5 until 11:59 PM ET on August 12, 2026, at 1-800-770-2030 (domestic) or 1-609-800-9909 (international), using the same passcode.

Market Context

The two tag-matched precedents were +0.71% and -4.87%, leaving a mixed historical benchmark for this...

Analysis

The two tag-matched precedents were +0.71% and -4.87%, leaving a mixed historical benchmark for this earnings-date announcement. Vanda’s active S-3 shelf, with up to $200,000,000 registered, is additional financing context to monitor.

Key Figures

Reporting period: Q2 2026 Results release date: August 5, 2026 Conference call time: 4:30 PM ET +1 more

4 metrics

Reporting period Q2 2026 Financial results

Results release date August 5, 2026 After market close

Conference call time 4:30 PM ET August 5, 2026

Replay availability 8:30 PM ET August 5 to 11:59 PM ET August 12, 2026 Conference call replay

Previous Earnings date Reports

2 past events · Latest: Apr 29 (Positive)

Same Type Pattern 2 events

Date	Event	Sentiment	24h Move	Catalyst
Apr 29	Earnings date	Positive	+0.7%	Shares rose 0.71% in 24 hours following the scheduled first-quarter results announcement.
Feb 04	Earnings date	Negative	-4.9%	Shares fell 4.87% in 24 hours following the scheduled fourth-quarter results announcement.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Tag-matched earnings-date announcements produced mixed 24-hour reactions, with one positive move and one negative move.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Conference Call and Webcast to Follow

WASHINGTON, July 29, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the second quarter 2026 on Wednesday, August 5, 2026, after the market closes.  

Vanda will host a conference call at 4:30 PM ET on Wednesday, August 5, 2026, during which management will discuss the second quarter 2026 financial results and other corporate activities. To participate in the conference call, please dial 1-888-596-4144 (domestic) or 1-646-968-2525 (international) and use passcode 1843107.

The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.

A replay of the call will be available on Wednesday, August 5, 2026, beginning at 8:30 PM ET and will be accessible until Wednesday, August 12, 2026, at 11:59 PM ET. The replay call-in number is 1-800-770-2030 for domestic callers and 1-609-800-9909 for international callers. The passcode number is 1843107.

About Vanda Pharmaceuticals Inc.

Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.

Corporate Contact: 
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer 
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com 

Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-second-quarter-2026-financial-results-on-august-5-2026-302838270.html

SOURCE Vanda Pharmaceuticals Inc.

FAQ

When will Vanda Pharmaceuticals (VNDA) report its Q2 2026 earnings?

Vanda Pharmaceuticals will report its Q2 2026 financial results on Wednesday, August 5, 2026, after the market closes. According to Vanda, the release will be followed by a management conference call and webcast at 4:30 PM ET the same day.

What time is Vanda Pharmaceuticals' (VNDA) Q2 2026 earnings conference call?

Vanda Pharmaceuticals will hold its Q2 2026 earnings conference call at 4:30 PM ET on Wednesday, August 5, 2026. According to Vanda, the call will cover quarterly financial results and other corporate activities and will be accessible by phone and webcast.

How can investors access the Vanda Pharmaceuticals (VNDA) Q2 2026 earnings call?

Investors can access the Q2 2026 earnings call by dialing 1-888-596-4144 (domestic) or 1-646-968-2525 (international) with passcode 1843107. According to Vanda, the call will also be webcast live and archived on www.vandapharma.com.

Will there be a replay of the Vanda Pharmaceuticals (VNDA) Q2 2026 earnings call?

Yes, a replay of the Q2 2026 earnings call will be available from 8:30 PM ET on August 5, 2026. According to Vanda, replay access runs until 11:59 PM ET on August 12 via 1-800-770-2030 (domestic) or 1-609-800-9909 (international), passcode 1843107.

Where will the Vanda Pharmaceuticals (VNDA) Q2 2026 earnings webcast be available?

The Q2 2026 earnings webcast will be available on Vanda Pharmaceuticals' website, www.vandapharma.com. According to Vanda, investors should visit at least 15 minutes early to register, download, and install any required audio software before the 4:30 PM ET call.

What information will Vanda Pharmaceuticals (VNDA) cover during the Q2 2026 call?

The Q2 2026 call will cover Vanda Pharmaceuticals' second quarter 2026 financial results and other corporate activities. According to Vanda, management will host the call and webcast on August 5, 2026, starting at 4:30 PM ET for investors and analysts.